Search Results

BISPHOSPHONATES IN RENAL INSUFFICIENCY: COMPARISON OF ESTIMATED GLOMERULAR FILTRATION RATE METHODS

Authors: Burkiewicz, Jill S.; Griffin, Brooke L.; Komperda, Kathy E.

Source: Journal of the American Geriatrics Society, Volume 57, Number 12, December 2009 , pp. 2351-2353(3)

Publisher: Blackwell Publishing

Avoiding breaks with bisphosphonates is cost effective

Source: PharmacoEconomics and Outcomes News, Volume 1, Number 593, 2009-12-12 , pp. 5-5(1)

Publisher: Adis International

Metalloproteinases and their inhibitors—diagnostic and therapeutic opportunities in orthopedics

Authors: Pasternak, Björn; Aspenberg, Per

Source: Acta Orthopaedica, Volume 80, Number 6, December 2009 , pp. 693-703(11)

Publisher: Informa Healthcare

Bisphosphonates/various other drugs: Low-energy femoral fractures: 8 case reports

Source: Reactions, Volume 1, Number 1279, 2009-11-21 , pp. 11-12(2)

Publisher: Adis International

Anti-Tumour Effects of Bisphosphonates - What have we Learned from In Vivo Models?

Authors: Brown, H. K.; Holen, I.

Source: Current Cancer Drug Targets, Volume 9, Number 7, November 2009 , pp. 807-823(17)

Publisher: Bentham Science Publishers

Bisphosphonates in the Prevention of Disease Recurrence: Current Results and Ongoing Trials

Author: Gnant, M.

Source: Current Cancer Drug Targets, Volume 9, Number 7, November 2009 , pp. 824-833(10)

Publisher: Bentham Science Publishers

Targeted Therapies in Bone Sarcomas

Authors: Scotlandi, K.; Picci, P.; Kovar, H.

Source: Current Cancer Drug Targets, Volume 9, Number 7, November 2009 , pp. 843-853(11)

Publisher: Bentham Science Publishers

Challenging the Current Approaches to Multiple Myeloma-Related Bone Disease: From Bisphosphonates to Target Therapy

Authors: Tassone, P.; Tagliaferri, P.; Rossi, M.; Calimeri, T.; Bulotta, A.; Abbruzzese, A.; Caraglia, M.; Neri, P.

Source: Current Cancer Drug Targets, Volume 9, Number 7, November 2009 , pp. 854-870(17)

Publisher: Bentham Science Publishers

Review of calciphylaxis and treatment of a severe case after kidney transplantation with iloprost in combination with hyperbaric oxygen and cultured autologous fibrin-based skin substitutes

Authors: Alikadic, Nadja; Kovac, Damjan; Krasna, Metka; Lindic, Jelka; Sabovic, Miso; Tomazic, Janez; Jeras, Matjaz; Smrke, Dragica

Source: Clinical Transplantation, Volume 23, Number 6, November/December 2009 , pp. 968-974(7)

Publisher: Blackwell Publishing

Treatment of Bone Metastases in Lung Cancer: The Actual Role of Zoledronic Acid

Authors: Ricciardi, Serena; de Marinis, Filippo

Source: Reviews on Recent Clinical Trials, Volume 4, Number 3, September 2009 , pp. 205-211(7)

Publisher: Bentham Science Publishers

Strategies for the targeted delivery of therapeutics for osteosarcoma

Author: Hughes, Dennis PM

Source: Expert Opinion on Drug Delivery, Volume 6, Number 12, December 2009 , pp. 1311-1321(11)

Publisher: Informa Healthcare

Bisphosphonate use doubles risk of particular fractures

Source: Reactions, Volume 1, Number 1281, 2009-12-05 , pp. 3-3(1)

Publisher: Adis International

Supportive Therapies in Multiple Myeloma

Authors: Gleason, Charise; Nooka, Ajay; Lonial, Sagar

Source: Journal of the National Comprehensive Cancer Network (JNCCN), Volume 7, Number 9, October 2009 , pp. 971-979(9)

Publisher: Cold Spring Publishing, LLC

Osteoporosis management: a perspective based on bisphosphonate data from randomised clinical trials and observational databases

Authors: Boonen, S.; Kay, R.; Cooper, C.; Haentjens, P.; Vanderschueren, D.; Callewaert, F.; Milisen, K.; Ferrari, S.

Source: International Journal of Clinical Practice, Volume 63, Number 12, December 2009 , pp. 1792-1804(13)

Publisher: Blackwell Publishing

Bone signaling pathways and treatment of osteoporosis

Authors: Gogakos, Apostolos I; Cheung, Moira S; Bassett, JH Duncan; Williams, Graham R

Source: Expert Review of Endocrinology and Metabolism, Volume 4, Number 6, November 2009 , pp. 639-650(12)

Publisher: Expert Reviews

Paget's disease of bone

Authors: Matthews, Brya; Cundy, Tim

Source: Expert Review of Endocrinology and Metabolism, Volume 4, Number 6, November 2009 , pp. 651-668(18)

Publisher: Expert Reviews

Preserving bone health in patients with hormone-sensitive prostate cancer: the role of bisphosphonates

Authors: Saad, Fred; Abrahamsson, Per-Anders; Miller, Kurt

Source: BJU International, Volume 104, Number 11, December 2009 , pp. 1573-1579(7)

Publisher: Blackwell Publishing

Alendronate decreases the fracture risk in patients with prostate cancer on androgen-deprivation therapy and with severe osteopenia or osteoporosis

Authors: Planas, Jacques; Trilla, Enrique; Raventós, Carles; Cecchini, Lluis; Orsola, Anna; Salvador, Carles; Placer, Jose; Encabo, Gloria; Morote, Juan

Source: BJU International, Volume 104, Number 11, December 2009 , pp. 1637-1640(4)

Publisher: Blackwell Publishing

Bisphosphonates and the risk of ONJ

Source: Reactions, Volume 1, Number 1278, 2009-11-14 , pp. 3-3(1)

Publisher: Adis International

Bisphosphonates and oral surgery

Author: Oliver, R.

Source: Oral Surgery, Volume 2, Number 2, May 2009 , pp. 56-63(8)

Publisher: Blackwell Publishing